• SENSEX 71,909.70
    -570.59 (--0.79%)
  • BANKNIFTY 54,450.75
    -182.30 (--0.33%)
  • ICICI Bank
    1,305.50 1,187.55(%)
  • NSE
    1,735.10 1,735.10(%)
  • Moneyview
    62.00 62.00(%)
  • HDFC Bank
    721.45 1,020.35(%)
  • Reliance Industries
    1,161.00 1,161.00(%)
  • Bharti Airtel
    1,726.05 1,726.05(%)
  • Kotak Mah. Bank
    435.55 452.98(%)
  • Infosys
    1,035.00 1,727.85(%)
  • Eternal
    309.80 212.55(%)
  • Molbio Diagnosti
    1,569.80 1,686.50(%)
  • SBI
    945.55 857.30(%)
  • Hero Motors
    167.80 167.80(%)
  • PB Fintech.
    965.00 965.00(%)
  • M & M
    2,812.60 2,812.60(%)
  • T R I L
    298.70 501.25(%)
  • Cupid
    314.40 314.40(%)
  • Ather Energy
    1,372.85 566.00(%)
  • Bank of Baroda
    234.00 325.55(%)
  • A-One Steels
    469.45 469.45(%)
  • Maruti Suzuki
    11,304.30 11,304.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venus Remedies Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4791.0
  • ISIN : INE411B01019
1,796.70 1 (0.03%)
  • As on 01 Oct 2026 (EOD)

  • Today’s Low

    1,715.00

  • Today’s High

    1,880.00

  • Open

    1,877.00

  • Perv Close

    1,796.10

  • 52W Low

    432.10

  • 52W High

    2,044.30

Key Indicators

  • P/E(TTM)

    21.08

  • Mar.Cap (₹Cr.)

    2,401.65

  • Div & Yield %

    0.56

  • Book Value(₹)

    515.92

  • Debt-Equity Ratio

    0.03

  • AGM Date

    01-Oct-2026

  • EPS

    84.64

  • P/E Ratio

    21.08

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    2,401.65

  • RONW (%)

    6.01

  • ROCE (%)

    8.52

Score Board

  • Equity (₹ in Cr.)

    13.37

  • BV (₹)

    515.90

  • Sales( ₹ in Cr.)

    768.73

  • NP (in Cr.)

    91.88

  • NP Var(%)

    144.0

  • Div%

    100.0

  • CPS (₹)

    87.20

  • EPS (₹)

    68.70

  • Traded Value (₹ in Lakhs)

    2,385.21

  • 52 Week High

    2,044.30

  • 52 Week Low

    432.10

  • Price BSE

    1784.0

  • Price NSE

    1,797.00

  • Market Capital( in Cr.)

    2,385.21

  • P/C Ratio

    20.50

  • P/E Ratio

    26.00

  • Price Vs.BV

    68.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 768.73 644.47 575.21 537.66 576.71 514.62
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 768.73 644.47 575.21 537.66 576.71 514.62
Other Income 11.45 25.69 11.32 10.17 8.43 50.37
Stock Adjustments 11.47 -0.93 5.00 -14.26 -3.19 7.36
Total Income 791.65 669.23 591.53 533.57 581.95 572.35
EXPENDITURE :            
Raw Materials 398.72 373.86 357.22 322.44 374.31 344.04
Power and Fuel Cost 6.43 4.91 4.99 4.17 3.78 3.39
Employee Cost 79.66 67.21 57.57 47.67 43.75 35.89
Other Manufacturing Expenses 16.44 12.34 10.07 6.18 6.47 4.51
Selling and Administration Expenses 133.76 109.58 89.17 81.16 76.40 87.29
Miscellaneous Expenses 1.28 0.64 0.31 0.26 0.00 9.17
Employee Benefit Expenses 79.66 67.21 57.57 47.67 43.75 35.89
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 636.29 568.54 519.33 461.88 504.71 484.28
Operating Profit 155.37 100.69 72.21 71.70 77.25 88.07
Interest 0.00 0.00 0.00 0.00 0.00 12.73
Gross Profit 155.37 100.69 72.21 71.70 77.25 75.34
Depreciation 24.69 21.62 25.55 31.37 32.58 34.28
Profit Before Tax 130.68 79.07 46.66 40.33 44.67 41.06
Current Tax 32.89 21.86 12.22 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.52 4.65 3.93 11.36 -4.32 -13.21
Reported Net Profit 99.31 52.56 30.50 28.96 48.99 54.27
Extraordinary Items 7.43 14.98 0.37 0.01 0.00 23.44
Adjusted Net Profit 91.88 37.58 30.13 28.95 48.99 30.83
Adjustment below Net Profit 0.11 -0.48 -0.19 -0.46 0.24 -0.10
P & L Balance brought forward 247.15 195.07 164.76 136.26 87.02 32.85
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 346.58 247.15 195.07 164.76 136.26 87.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 10.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 74.29 39.32 22.82 21.67 36.65 43.97
Earnings Per Share(Adj)-Unit Curr 74.29 39.32 22.82 21.67 36.65 43.97
Book Value 515.92 441.01 380.48 357.63 336.21 313.10
Book Value(Adj)-Unit Curr 515.92 441.01 380.48 357.63 336.21 313.10

Shareholding Pattern

  • Promoter Group

    41.76%

  • Public Share Holding

    58.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,300,000 17.21 2,300,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,281,997 24.55 3,281,997 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,581,997 41.76 5,581,997 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 390,228 2.92 390,228 36
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 118,649 0.89 118,649 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 508,877 3.81 508,877 41
2] Non Institution
Bodies Corporate 397,709 2.98 397,409 151
Clearing Members 59,496 0.45 59,496 27
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 214,128 1.60 214,128 489
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 259,414 1.94 259,414 538
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,737,102 13.00 1,737,102 33
Individuals holding nominal share capital up to Rs. 1 lakh 4,186,465 31.32 4,085,423 20,596
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 133,841 1.00 133,841 1
Sub Total 7,276,114 54.43 7,174,772 21,859
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,366,988 100.00 13,265,646 21,905

Company Background

Venus Remedies LtdPharmaceuticals - Indian - Formulations

  • Venus Remedies Ltd
  • BSE Code : 4791.0
  • ISIN : INE411B01019

  • Incorporation Year

    1989

  • Registered Office

    S C No 857 Cabin No 10 2nd Flr
    N A C Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

  • FAX

  • Chairman

    Pawan Chaudhary

  • Managing Director

    Pawan Chaudhary

  • Company Secretary

    Neha Arora

  • Auditor

    J K Jain & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Venus Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 26,832.10 7,217.19 6,929.05 35.31 43.78
Astrazeneca Phar 6,030.45 2,304.07 2,275.58 88.88 27.86
Glaxosmi. Pharma 2,774.50 3,932.76 3,790.20 44.32 58.17
Novartis India 1,967.85 393.10 354.33 49.69 15.94
Cipla 1,346.85 20,102.60 18,979.95 35.40 13.88
Bliss GVS Pharma 684.20 773.53 729.81 63.59 12.51
Fermenta Biotec. 551.35 474.15 450.25 25.74 18.77
Amrutanjan Healt 513.80 520.13 502.55 27.52 24.16
Guj. Themis Bio. 382.35 168.25 165.82 102.23 18.05
Ambalal Sarabhai 37.92 19.52 3.94 70.22 6.77